These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
423 related items for PubMed ID: 21107741
1. Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy. Houssami N, Ambrogetti D, Marinovich ML, Bianchi S, Macaskill P, Vezzosi V, Mamounas EP, Ciatto S. Ann Surg Oncol; 2011 May; 18(5):1364-71. PubMed ID: 21107741 [Abstract] [Full Text] [Related]
2. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings]. Piubello Q, Montemezzi S, D'Atri C. Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993 [Abstract] [Full Text] [Related]
3. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Renshaw AA, Derhagopian RP, Martinez P, Gould EW. Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208 [Abstract] [Full Text] [Related]
7. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy. Caughran JL, Vicini FA, Kestin LL, Dekhne NS, Benitez PR, Goldstein NS. Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632 [Abstract] [Full Text] [Related]
8. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy? McGhan LJ, Pockaj BA, Wasif N, Giurescu ME, McCullough AE, Gray RJ. Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619 [Abstract] [Full Text] [Related]
12. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. Kurniawan ED, Rose A, Mou A, Buchanan M, Collins JP, Wong MH, Miller JA, Mann GB. Arch Surg; 2010 Nov; 145(11):1098-104. PubMed ID: 21079099 [Abstract] [Full Text] [Related]
13. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Rutstein LA, Johnson RR, Poller WR, Dabbs D, Groblewski J, Rakitt T, Tsung A, Kirchner T, Sumkin J, Keenan D, Soran A, Ahrendt G, Falk JS. Breast J; 2007 Nov; 13(3):251-7. PubMed ID: 17461899 [Abstract] [Full Text] [Related]
15. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Kim J, Han W, Lee JW, You JM, Shin HC, Ahn SK, Moon HG, Cho N, Moon WK, Park IA, Noh DY. Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854 [Abstract] [Full Text] [Related]
17. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience. Killebrew LK, Oneson RH. Breast J; 2006 Oct; 12(4):302-8. PubMed ID: 16848839 [Abstract] [Full Text] [Related]